Skip to main content

Table 1 Baseline characteristics for study participants by clinical trial (n = 1495)

From: Subclinical carotid artery atherosclerosis and cognitive function in older adults

Variable

BVAIT (n = 504)a

WISH (n = 349)a

ELITE (n = 642)a

Combined

Mean ± SD or number (%)

Age (years)

61.5 ± 9.9

61.4 ± 7.1

60.6 ± 6.9

61.1 ± 8.1

Sex

 Male

308 (61.1%)

0 (0%)

0 (0%)

308 (20.6%)

 Female

196 (38.9%)

349 (100%)

642 (100%)

1187 (79.4%)

Race

 Non-Hispanic White

326 (64.7%)

222 (63.6%)

439 (68.4%)

987 (66.0%)

 Non-Hispanic Black

75 (14.9%)

21 (6.0%)

60 (9.3%)

156 (10.4%)

 Hispanic

55 (10.9%)

55 (15.8%)

90 (14.0%)

200 (13.4%)

 Asian or Pacific Islander

45 (8.9%)

38 (10.9%)

53 (8.3%)

136 (9.1%)

 Others

3 (0.6%)

13 (3.7%)

0 (0%)

16 (1.1%)

Education (# of years)

15.7 ± 2.0b

15.8 ± 2.0

16.0 ± 1.9

15.9 ± 2.0

Annual income

$64.6k ± $29.7kb

$65.3k ± $31.3kb

$69.0k ± $31.0kb

$66.7k ± $30.7k

Marital status

 Single, never married

45 (8.9%)b

33 (9.5%)

50 (7.8%)

128 (8.6%)

 Married

323 (64.1%)b

197 (56.4%)

368 (57.3%)

888 (59.4%)

 Separated

5 (1.0%)b

7 (2.0%)

12 (1.9%)

24 (1.6%)

 Divorced

89 (17.7%)b

80 (22.9%)

171 (26.6%)

340 (22.8%)

 Widowed

41 (8.1%)b

32 (9.2%)

41 (6.4%)

114 (7.6%)

Current smoker

17 (3.4%)b

8 (2.3%)

22 (3.4%)

47 (3.2%)

Alcohol user

221 (43.8%)

152 (43.6%)

313 (48.8%)

686 (45.9%)

Use of anti-hypertensives at baseline

190 (37.7%)

117 (33.5%)

220 (34.3%)

527 (35.3%)

Use of cholesterol lowering medication at baseline

81 (16.1%)

72 (20.6%)

126 (19.6%)

279 (18.7%)

BMI (kg/m2)

28.1 ± 4.9

26.6 ± 5.2

27.2 ± 5.4b

27.4 ± 5.2

Blood pressure (mmHg)

 Systolic

127.0 ±15.6

117.9 ± 13.9

116.5 ± 13.7b

120.4 ± 15.2

 Diastolic

78.7 ± 8.9

75.0 ± 8.6

74.5 ± 8.4b

76.0 ± 8.8

ApoE4+

103 (22.2%)b

86 (25.7%)b

197 (30.9%)b

386 (26.9%)

CES-D scorec

6.2 ± 6.6

7.3 ± 6.82

8.3 ± 8.6

7.4 ± 7.6

CES-D score ≥ 16d

44 (8.7%)

40 (11.5%)

113 (17.6%)

197 (13.2%)

Average CIMT (mm, over 1 cm segment)

0.75 ± 0.15

0.81 ± 0.10

0.77 ± 0.11

0.77 ± 0.12

Executive function composite score

− 0.012 ± 1.369

− 0.005 ± 1.323

− 0.002 ± 1.360

− 0.006 ± 1.353

Verbal memory composite score

− 0.005 ± 1.317

− 0.006 ± 1.357

0.001 ± 1.348

− 0.003 ± 1.339

Visual memory composite score

0.001 ± 1.108

0.001 ±1.107

0 ± 1.103

0.001 ± 1.105

Global cognition composite score

0.014 ± 1.745

0.002 ± 1.715

− 0.001 ± 1.827

0.005 ± 1.773

  1. aTwo participants in BVAIT and 1 participant in both WISH and ELITE each did not complete the baseline cognitive exam
  2. bDiffering sample sizes: Education, BVAIT: n = 503. Income, BVAIT: n = 472; WISH: n = 319; ELITE: n = 597. Marital status, BVAIT: n = 503. Current smoker, BVAIT: n = 503. BMI, ELITE: n = 641. Blood pressure, ELITE: n = 640. ApoE4 genotype, BVAIT: n = 463; WISH: n = 334; ELITE: n = 637. CES-D score, WISH: n = 348
  3. cCES-D scores range from 0-60, with higher scores indicating more depressive symptomatology [22]
  4. dA score of 16 or higher on the CES-D indicates concern for clinical depression [30]